Cannell Capital - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 62 filers reported holding OVID THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cannell Capital ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$58,360
+38.7%
22,6200.0%0.01%
+37.5%
Q4 2022$42,073
+0.2%
22,6200.0%0.01%
-20.0%
Q3 2022$42,000
+223.1%
22,620
+280.2%
0.01%
+233.3%
Q2 2022$13,0005,9490.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$5,06820.50%
Madison Avenue Partners, LP 3,648,509$14,010,2751.99%
CHI Advisors LLC 864,822$3,320,9161.32%
EcoR1 Capital, LLC 6,117,400$23,490,8160.79%
Rubric Capital Management LP 5,445,910$20,912,2940.78%
BVF INC/IL 6,851,051$26,308,0360.71%
Artal Group S.A. 2,500,000$9,6000.41%
DCF Advisers, LLC 30,430$116,8510.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 458,700$1,761,4080.04%
ACADIAN ASSET MANAGEMENT LLC 1,701,228$6,5310.03%
View complete list of OVID THERAPEUTICS INC shareholders